Connect Biopharma Files 8-K with Exhibits
Ticker: CNTB · Form: 8-K · Filed: Apr 23, 2026 · CIK: 0001835268
Sentiment: neutral
Topics: disclosure, exhibit
TL;DR
Connect Biopharma dropped an 8-K, check the exhibits for the latest news.
AI Summary
Connect Biopharma Holdings Ltd filed an 8-K on April 23, 2026, primarily for Regulation FD Disclosure, Other Events, and Financial Statements/Exhibits. The filing includes an exhibit (EX-99.1) related to a 'seabreeze interi' document, though specific details of this exhibit are not provided in the filing summary.
Why It Matters
This 8-K filing indicates that Connect Biopharma Holdings Ltd is disclosing material information or events, which could impact investors' understanding of the company's current status.
Risk Assessment
Risk Level: low — The filing is a standard 8-K for disclosures and exhibits, without immediate indication of significant negative events.
Key Players & Entities
- Connect Biopharma Holdings Ltd (company) — Filer
- 0001835268 (company) — CIK
- 2026-04-23 (date) — Filing Date
- EX-99.1 (document) — Exhibit
FAQ
What is the primary purpose of this 8-K filing?
This 8-K filing is primarily for Regulation FD Disclosure (Item 7.01), Other Events (Item 8.01), and Financial Statements and Exhibits (Item 9.01).
What is the filing date of this 8-K?
The filing date of this 8-K is April 23, 2026.
What specific exhibit is mentioned in the filing?
The filing mentions Exhibit EX-99.1, titled 'exhibit991-seabreezeinteri.htm'.
What is the CIK number for Connect Biopharma Holdings Ltd?
The CIK number for Connect Biopharma Holdings Ltd is 0001835268.
Where is Connect Biopharma Holdings Ltd located?
Connect Biopharma Holdings Ltd's mailing and business address is 3580 Carmel Mountain Road, Suite 200, San Diego, CA 92130.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 23, 2026 regarding Connect Biopharma Holdings Ltd (CNTB).